SCAIOLI V

Last name: SCAIOLI V

2016 (v1)

Publication

Metadata-only

Nerve conduction velocity in CMT1A: what else can we tell?

Manganelli F Pisciotta C Reilly MM

Background and purpose: Charcot-Marie-Tooth disease (CMT) type 1A is characterized by uniformly reduced nerve conduction velocity (NCV) that is fully penetrant since the first years of life, remains fairly stable through the life and does not correlate with disability whereas compound muscular action potential (CMAP) amplitude does. The aim of...

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Expanding the spectrum of genes responsible for hereditary motor neuropathies.

Previtali SC Zhao E Lazarevic D

Background Inherited peripheral neuropathies (IPNs) represent a broad group of genetically and clinically heterogeneous disorders, including axonal Charcot-Marie-Tooth type 2 (CMT2) and hereditary motor neuropathy (HMN). Approximately 60%–70% of cases with HMN/CMT2 still remain without a genetic diagnosis. Interestingly, mutations in HMN/CMT2...

Uploaded on: April 14, 2023
2006 (v1)

Publication

Metadata-only

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol

Pareyson D Schenone A Fabrizi GM

No description

Uploaded on: April 14, 2023
2011 (v1)

Publication

Metadata-only

Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.

Pareyson D Reilly MM Schenone A

No description

Uploaded on: March 31, 2023

SCAIOLI V

Recent uploads